An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major

Inflammatory monocytes regulate Th1 oriented immunity to CpG adjuvanted protein vaccines through production of IL-12

(2017) S. De Koker et al.   Scientific Reports

A new perspective on cutaneous leishmaniasis—Implications for global prevalence and burden of disease estimates

(2017) Freddie Bailey et al.   PLoS Neglected Tropical Diseases

Parasite Carbohydrate Vaccines

(2017) Jonnel A. Jaurigue et al.   Frontiers in Cellular and Infection Microbiology

Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa

(2016) Rebecca Du et al.   PLoS Neglected Tropical Diseases

Cutaneous Leishmaniasis Vaccination: A Matter of Quality

(2016) Paula Mello De Luca et al.   Frontiers in Immunology

Leishmania vaccine development: exploiting the host–vector–parasite interface

(2015) SG Reed et al.   Expert Review of Vaccines

Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates

(2015) Yari Cabezas et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates

(2015) Fabiano Oliveira et al.   Science Translational Medicine

Gut Microbiota Elicits a Protective Immune Response against Malaria Transmission

(2014) Bahtiyar Yilmaz et al.   CELL

Identifying vaccine targets for anti-leishmanial vaccine development

(2014) Shyam Sundar et al.   Expert Review of Vaccines

Eosinophils and mast cells in leishmaniasis

(2014) Nilda E. Rodríguez et al.   IMMUNOLOGIC RESEARCH

What’s behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity

(2014) Maha Abdeladhim et al.   INFECTION GENETICS AND EVOLUTION

Detection of high levels of anti-α-galactosyl antibodies in sera of patients with Old World cutaneous leishmaniasis: a possible tool for diagnosis and biomarker for cure in an elimination setting

(2014) WALEED S. AL-SALEM et al.   PARASITOLOGY

Vaccination with Leishmania mexicana LPG induces PD-1 in CD8+ and PD-L2 in macrophages thereby suppressing the immune response: A model to assess vaccine efficacy

(2014) M.B. Martínez Salazar et al.   VACCINE

Direct Comparison of the Efficacy and Safety of Oral Treatments with Oleylphosphocholine (OlPC) and Miltefosine in a Mouse Model of L. major Cutaneous Leishmaniasis

(2014) Anny Fortin et al.   PLoS Neglected Tropical Diseases

An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis

(2013) Israel Cruz et al.   EXPERIMENTAL PARASITOLOGY

Potential use of synthetic α-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease

(2013) Roger A. Ashmus et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis

(2012) Lynn Soong et al.   Seminars in Immunopathology

Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: Modulation of Innate Immune System and Variations in Carbohydrate Structure

(2012) Rafael Ramiro Assis et al.   PLoS Neglected Tropical Diseases

Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model

(2012) Fabienne Tacchini-Cottier et al.   Frontiers in Immunology

Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccines

(2011) A. V. Nikolaev et al.   BIOCHEMISTRY-MOSCOW

Glycoconjugates in New World species of Leishmania: Polymorphisms in lipophosphoglycan and glycoinositolphospholipids and interaction with hosts

(2011) Rafael Ramiro de Assis et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Vaccine candidates for leishmaniasis: A review

(2011) Rajeev Nagill et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Leishmania antimony resistance: what we know what we can learn from the field

(2011) Khatima Aït-Oudhia et al.   PARASITOLOGY RESEARCH

Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis

(2011) Márcio Sobreira Silva Araújo et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease Patients

(2009) Tomas Duffy et al.   PLoS Neglected Tropical Diseases

Proteophosophoglycans Regurgitated by Leishmania-Infected Sand Flies Target the L-Arginine Metabolism of Host Macrophages to Promote Parasite Survival

(2009) Matthew Rogers et al.   PLoS Pathogens

Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity

(2009) Nathan C. Peters et al.   PLoS Pathogens

First generation leishmaniasis vaccines: A review of field efficacy trials

(2008) Sassan Noazin et al.   VACCINE